Singular Genomics Systems, Inc. (OMIC)
USD 20.01
(0.0%)
USD 20.01
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 265.46 Million USD | -19.06% |
| 2022 | 327.97 Million USD | -7.78% |
| 2021 | 355.64 Million USD | 1065.98% |
| 2020 | 30.5 Million USD | -36.68% |
| 2019 | 48.17 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 239.1 Million USD | -9.93% |
| 2024 Q2 | 220 Million USD | -7.99% |
| 2023 FY | 265.46 Million USD | -19.06% |
| 2023 Q3 | 284.51 Million USD | 0.19% |
| 2023 Q2 | 283.97 Million USD | -7.03% |
| 2023 Q4 | 265.46 Million USD | -6.7% |
| 2023 Q1 | 305.46 Million USD | -6.86% |
| 2022 Q3 | 345.47 Million USD | -5.71% |
| 2022 Q1 | 342.11 Million USD | -3.81% |
| 2022 FY | 327.97 Million USD | -7.78% |
| 2022 Q4 | 327.97 Million USD | -5.07% |
| 2022 Q2 | 366.4 Million USD | 7.1% |
| 2021 Q4 | 355.64 Million USD | -4.09% |
| 2021 Q3 | 370.83 Million USD | -3.42% |
| 2021 Q2 | 383.98 Million USD | 146.74% |
| 2021 FY | 355.64 Million USD | 1065.98% |
| 2021 Q1 | 155.62 Million USD | 410.21% |
| 2020 Q4 | 30.5 Million USD | 0.0% |
| 2020 FY | 30.5 Million USD | -36.68% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 48.17 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | -47.18% |
| AngioDynamics, Inc. | 317.67 Million USD | 16.433% |
| AtriCure, Inc. | 613.93 Million USD | 56.76% |
| Avinger, Inc. | 13.77 Million USD | -1827.865% |
| Azenta, Inc. | 2.88 Billion USD | 90.801% |
| BioLife Solutions, Inc. | 412.71 Million USD | 35.678% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 97.723% |
| Daxor Corporation | 34.86 Million USD | -661.324% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -817.999% |
| Femasys Inc. | 27.75 Million USD | -856.437% |
| GlucoTrack, Inc. | 4.9 Million USD | -5312.171% |
| Harvard Bioscience, Inc. | 137.36 Million USD | -93.255% |
| Hologic, Inc. | 9.15 Billion USD | 97.101% |
| ICU Medical, Inc. | 4.37 Billion USD | 93.937% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 98.281% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -832.74% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 23.448% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -4168.808% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -4168.808% |
| Masimo Corporation | 3.04 Billion USD | 91.272% |
| Microbot Medical Inc. | 8.32 Million USD | -3088.027% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -54.417% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 88.583% |
| Nephros, Inc. | 11.86 Million USD | -2138.15% |
| NovoCure Limited | 1.14 Billion USD | 76.838% |
| NEXGEL, Inc. | 9.95 Million USD | -2566.67% |
| NEXGEL, Inc. | 9.95 Million USD | -2566.67% |
| OraSure Technologies, Inc. | 482.84 Million USD | 45.02% |
| Pro-Dex, Inc. | 54.21 Million USD | -389.701% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -336.595% |
| Predictive Oncology Inc. | 14.41 Million USD | -1741.315% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -1469.643% |
| QuidelOrtho Corporation | 8.56 Billion USD | 96.9% |
| Repligen Corporation | 2.82 Billion USD | 90.601% |
| Sanara MedTech Inc. | 73.87 Million USD | -259.365% |
| STAAR Surgical Company | 488.69 Million USD | 45.678% |
| Sharps Technology, Inc. | 11.78 Million USD | -2151.768% |
| Utah Medical Products, Inc. | 135.45 Million USD | -95.977% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 96.398% |
| Jin Medical International Ltd. | 32.9 Million USD | -706.806% |